Orthopedic implants market boom

Zimmer Biomet, Stryker, DePuy Synthes and Smith+Nephew together accounted for roughly 72% of global knee and hip replacement sales, underscoring concentrated market power among incumbents. (orthoworld.com) The 3D‑printed orthopedic implants segment is expanding fastest — Strategic Market Research projects a ~9.6% CAGR for 3D printing devices through 2030, driven by patient‑specific implants. (strategicmarketresearch.com) Hospitals adopting 3D‑printed implants now number in the thousands, with one industry estimate citing about 4,200 facilities using the technology. (marketgrowthreports.com) Robotic assistance is scaling alongside implants: Grand View Research estimated the orthopedic surgical robots market at $743.3 million in 2023 and forecast it to reach $1.09 billion by 2030 as systems like MAKO and ROSA gain OR adoption. (grandviewresearch.com) Site‑of‑care shifts are changing post‑op pathways — same‑day discharge for elective total joint arthroplasty rose from under 1% in 2017 to over 30% in 2021 in U.S. data, reflecting migration to outpatient and ASC settings. (ascfocus.org) CMS policy moves helped enable that shift: Medicare removed total knee arthroplasty from its inpatient‑only list effective Jan. 1, 2018 and removed total hip procedures from the IPO in 2020. (cms.gov) Market reports flag orthobiologics, spinal implants and trauma fixation as growth pockets within the broader implants category, with Allied Market Research listing those product types in its segmentation and forecasts. (prnewswire.com) ORTHOWORLD data show the joint‑replacement segment itself grew ~7.5% in 2023, reaching about $21.5 billion, highlighting procedure rebound after pandemic slowdowns. (bonezonepub.com) Strategic activity is high: dominant firms have prioritized acquisitions, partnerships and platform launches to protect share and commercialize digital planning and implant‑specific technologies, according to recent market analyses. (marketsandmarkets.com)